Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Politics

Trump FDA pick clears last hurdle after flipping vaccine question on Dem in confirmation hearing

by March 26, 2025
March 26, 2025

President Donald Trump’s choice to lead the Food and Drug Administration (FDA), Johns Hopkins School of Medicine professor Dr. Marty Makary, cleared a key vote in the Senate on Tuesday, the last such test before his final confirmation vote. 

The Senate voted 56-44 to invoke cloture on the nomination. 

A final vote to confirm the FDA nominee is slated for after 8 p.m. Tuesday. 

Makary, a former Fox News medical contributor, went before the Senate Committee on Health, Education, Labor and Pensions (HELP) earlier this month and answered various questions on vaccines, chronic illness, food safety and abortion. 

During his hearing, the nominee faced scrutiny over an FDA vaccine meeting that was reportedly postponed at the last minute. 

‘So if you are confirmed, will you commit to immediately reschedule that FDA Vaccine Advisory Committee meeting to get the expert views?’ Sen. Patty Murray, D-Wash., asked Makary at the time. 

He responded that he ‘would reevaluate which topics deserve a convening of the advisory committee members on [Vaccines and Related Biological Products Advisory Committee] and which may not require a convening.’ 

When this response wasn’t good enough for Murray, Makary flipped the question, telling her to confront the Biden administration. ‘Well, you can ask the Biden administration that chose not to convene the committee meeting for the COVID vaccine booster,’ he said. 

He was referring to the Biden administration in 2021 pushing through FDA approval for a COVID-19 booster for everyone over the age of 18. 

‘The FDA did not hold a meeting of the Vaccines and Related Biological Products Advisory Committee on these actions,’ read a press release at the time, ‘as the agency previously convened the committee for extensive discussions regarding the use of booster doses of COVID-19 vaccines and, after review of both Pfizer’s and Moderna’s EUA requests, the FDA concluded that the requests do not raise questions that would benefit from additional discussion by committee members.’

Committee member Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, criticized the administration’s move, saying, ‘We’re being asked to approve this as a three-dose vaccine for people 16 years of age and older, without any clear evidence if the third dose for a younger person when compared to an elderly person is of value.’

Makary has long been a critic of the administration he is poised to lead. He wrote an opinion piece in 2021, calling for ‘fresh leadership at the FDA to change the culture at the agency and promote scientific advancement, not hinder it.’

‘We now have a generational opportunity in American healthcare,’ he said at his hearing. ‘President Trump and Secretary Kennedy’s focus on healthy foods has galvanized a grassroots movement in America. Childhood obesity is not a willpower problem, and the rise of early-onset Alzheimer’s is not a genetic cause. We should be, and we will, be addressing food as it impacts our health.’

This post appeared first on FOX NEWS
0
FacebookTwitterGoogle +Pinterest
previous post
Trump’s pick to lead NIH, Dr. Jay Bhattacharya, confirmed by Senate in party-line vote
next post
Trump orders FBI to declassify documents from ‘Crossfire Hurricane’ Russia investigation

You may also like

Title 42 immigration fight stalls mammoth $1.7 trillion...

December 22, 2022

Trump-backed spending bill goes down in flames as...

December 20, 2024

President Trump Warned Us About Biden: “If He’s...

September 26, 2022

WAYNE ROOT: Las Vegas Oddsmaker Says Bet the...

October 21, 2022

Former US Senator James Abourezk dead at 92

February 25, 2023

‘Of course I support the pardon of my...

December 2, 2024

Trump Trolls Biden For Being Seated 14 Rows...

September 20, 2022

Rapper/Actor Ice Cube Claims He Lost Movie Role...

November 24, 2022

Gabbard moves presidential daily intelligence brief staff from...

May 14, 2025

Philadelphia Wawa Robbed by Man Armed With a...

November 30, 2022

Title 42 immigration fight stalls mammoth $1.7 trillion...

December 22, 2022

Trump-backed spending bill goes down in flames as...

December 20, 2024

President Trump Warned Us About Biden: “If He’s...

September 26, 2022

WAYNE ROOT: Las Vegas Oddsmaker Says Bet the...

October 21, 2022

Former US Senator James Abourezk dead at 92

February 25, 2023

‘Of course I support the pardon of my...

December 2, 2024

Trump Trolls Biden For Being Seated 14 Rows...

September 20, 2022

Rapper/Actor Ice Cube Claims He Lost Movie Role...

November 24, 2022

Gabbard moves presidential daily intelligence brief staff from...

May 14, 2025

Philadelphia Wawa Robbed by Man Armed With a...

November 30, 2022

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Israel’s actions against Iran create strategic opportunity for US in nuclear talks, experts say

      June 14, 2025
    • Israel strikes at the heart of Iran’s nuclear ambitions in Isfahan offensive

      June 14, 2025
    • Time for Israel to take out ‘head of the snake,’ target members of Iranian regime, says former IDF intel chief

      June 14, 2025
    • HMRC to slash physical post – unless you owe them money

      June 14, 2025
    • Corporate support for UK Pride festivals declines amid political backlash

      June 14, 2025
    • Metro Bank takeover approach adds to fears of London Stock Market exodus

      June 14, 2025

    Categories

    • Business (8,213)
    • Investing (2,035)
    • Politics (15,650)
    • Stocks (3,147)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved